These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 19712597)

  • 21. [Bibliographic databases and reference management software].
    Tomizawa Y
    Kyobu Geka; 2010 Jun; 63(6):480-5. PubMed ID: 20533740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of five full-text drug databases by pharmacy students, faculty, and librarians: do the groups agree?
    Kupferberg N; Jones Hartel L
    J Med Libr Assoc; 2004 Jan; 92(1):66-71. PubMed ID: 14762464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-drug interaction software in clinical practice: a systematic review.
    Roblek T; Vaupotic T; Mrhar A; Lainscak M
    Eur J Clin Pharmacol; 2015 Feb; 71(2):131-42. PubMed ID: 25529225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: a Delphi survey of oncology pharmacists.
    Chan A; Tan SH; Wong CM; Yap KY; Ko Y
    Clin Ther; 2009; 31 Pt 2():2379-86. PubMed ID: 20110047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FDA toxicity databases and real-time data entry.
    Arvidson KB
    Toxicol Appl Pharmacol; 2008 Nov; 233(1):17-9. PubMed ID: 18656494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing 4 classification systems for drug-related problems: processes and functions.
    Björkman IK; Sanner MA; Bernsten CB
    Res Social Adm Pharm; 2008 Dec; 4(4):320-31. PubMed ID: 19064239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of nursing-specific drug information PDA databases used as clinical decision support tools.
    Polen HH; Clauson KA; Thomson W; Zapantis A; Lou JQ
    Int J Med Inform; 2009 Oct; 78(10):679-87. PubMed ID: 19640779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and implementation of a portal for the medical equipment market: MEDICOM.
    Palamas S; Kalivas D; Panou-Diamandi O; Zeelenberg C; van Nimwegen C
    J Med Internet Res; 2001; 3(4):E32. PubMed ID: 11772547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and patient awareness of selected potential drug interactions with self-medication.
    Indermitte J; Reber D; Beutler M; Bruppacher R; Hersberger KE
    J Clin Pharm Ther; 2007 Apr; 32(2):149-59. PubMed ID: 17381665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating Australia's National Medicines Policy using geographical mapping.
    Roughead EE; Monteith GR; Harvey KJ; Tett SE
    Intern Med J; 2002 Mar; 32(3):66-71. PubMed ID: 11885845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of drug interaction document citation in nine on-line bibliographic databases.
    Barillot MJ; Sarrut B; Doreau CG
    Ann Pharmacother; 1997 Jan; 31(1):45-9. PubMed ID: 8997464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SuperDrug: a conformational drug database.
    Goede A; Dunkel M; Mester N; Frommel C; Preissner R
    Bioinformatics; 2005 May; 21(9):1751-3. PubMed ID: 15691861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Network analysis of adverse drug interactions.
    Takarabe M; Okuda S; Itoh M; Tokimatsu T; Goto S; Kanehisa M
    Genome Inform; 2008; 20():252-9. PubMed ID: 19425139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and implementation of an audit trail in compliance with US regulations.
    Jiang K; Cao X
    Clin Trials; 2011 Oct; 8(5):624-33. PubMed ID: 21900341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Heavy consumers of drugs--seen from the viewpoint of the community pharmacist].
    Mellbye KS; Berg C
    Tidsskr Nor Laegeforen; 2004 Dec; 124(23):3069-71. PubMed ID: 15586191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug Interaction Database Sensitivity With Oral Antineoplastics: An Exploratory Analysis.
    Bossaer JB; Thomas CM
    J Oncol Pract; 2017 Mar; 13(3):e217-e222. PubMed ID: 28095171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Building a better drug database.
    Simonian AI
    Am J Health Syst Pharm; 2004 Feb; 61(4):397-400. PubMed ID: 15011770
    [No Abstract]   [Full Text] [Related]  

  • 39. OncoRx-IQ: a tool for quality assessment of online anticancer drug interactions.
    Yap KY; Raaj S; Chan A
    Int J Qual Health Care; 2010 Apr; 22(2):93-106. PubMed ID: 20172863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of resources for analyzing drug interactions.
    Patel RI; Beckett RD
    J Med Libr Assoc; 2016 Oct; 104(4):290-295. PubMed ID: 27822150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.